|
Liens> logiciels Voici une revue d'adresses internet où il est
possible de trouver des informations concernant des logiciels de PK
principalement:
|
The Laboratory of Applied Pharmacokinetics (LAPK) of the School of
Medicine at the University of Southern California is a resource for
optimal study and control of pharmacokinetic systems and for
individualized drug therapy supported in part by the National Library of
Medicine (NLM) and National Center for Research Resources (NCRR).
http://www.lapk.org |
La page d'accueil du célèbre NONMEM Project Group. Donne accès à des
résumés de discussions concernant NONMEM échangées sur internet, et à un
site de téléchargement des sous-routines pour NONMEM.
http://c255.ucsf.edu/ |
|
Le site de la Société SummitPK qui propose des choses diverses
concernant la PK et l’ADME dont des logiciels en démo ou non à
télécharger.
http://www.summitpk.com/
|
Le site de la Société.Simulation Plus, Inc éditeur de GastroPlus
logiciel de simulation de dissolution et d'absorption dans le tractus
gastro-intestinal
http://www.simulations-plus.com |
Le site de la Société Globomax
http://www.globomax.com/ |
Le site de la Société Graph Pad, éditeur de Graph Pad Prism logiciel de
traitement de données biologiques.
http://www.graphpad.com |
|
Le site de la Société Pharsight, éditeur de WinNonlin et WinNonmix.
http://www.pharsight.com/
|
DDI Predict 2009 Edition
By Aureus Pharma, Paris France, provides an instant graphical report
containing all potential drug-drug interactions between a drug candidate
and a large panel of marketed or withdrawn drugs. The predictions are
supported by calculation of the change of the AUC ratio based on the
plasma concentration of the drug candidate in the presence or absence of
enzyme inhibitors. The system uses a large library containing more than
7,000 inhibition and 8,000 PK data points, measured on 1,500 drugs
stored in the Aureus ADME database to calculate potential interactions.
The Aureus ADME Knowledge database contains a total 25,000 compounds,
3,500 metabolites, 365,000 biological data points, analyzed out from
more than 11,000 articles and FDA documents.
The new Edition extends the prediction of drug-drug interaction in cases
where multiple metabolic pathways are involved and provides new
functionalities including prediction of fraction metabolized (fm) based
on scaling factors (RAF, ISEF, Abundance), gut metabolism and others.
For More Information and contact see website
http://www.aureus-pharma.com or email
us at
info@aureus-pharma.com |
|
|
